Undervalued Small-Cap Growth Stocks on ASE January 2025

January 28, 2025

Growth Stocks

A company is considered a growth stock when it has grown its revenue significantly in the latest quarterly report.

American Stock Exchange

NYSE American, formerly known as the American Stock Exchange (ASE), and more recently as NYSE MKT, is an American stock exchange located in New York City.

Small, Micro and Nano-Cap

Stocks in the Small, Micro and Nano Market Cap groups have a market capitalization of less than $2 billion.

Our Valuation

A stock is considered undervalued if it trades at a discount to our valuation. To determine a stock’s intrinsic value, we developed an algorithm that uses 6 valuation models to determine the value of a company.* To learn more about stockcalc’s valuation methods, click here.

Undervalued Growth Stocks

Stocks in this category are held primarily for capital appreciation and while they present upside opportunity, they also present downside risk.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose Price ($)Valuation ($)Difference (%)Average Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
ACCS ACCESS Newswire - - 0.00 - 0 0.00 0.0
AEON AEON Biopharma - - 0.00 - 0 0.00 0.0
AIM AIM ImmunoTech - - 0.00 - 0 0.00 0.0
AIRI Air Industries - - 0.00 - 0 0.00 0.0
AMBI Ambipar Emergency - - 0.00 - 0 0.00 21.9
AMBO Ambow Education Holding - - 0.00 - 0 0.00 0.0
AMS American Shared Hospital - - 0.00 - 0 0.00 5.1
APT Alpha Pro Tech - - 0.00 - 0 0.00 14.3
AREN Arena Group Holdings - - 0.00 - 0 0.00 0.0
ARMN Aris Mining - - 0.00 - 0 0.00 0.0
All data provided as at market close January 27, 2025.

Company Details

ACCESS Newswire

ACCS:ASE

Close Price

-

Our Valuation

-

% Difference

0.00

Market Cap ($M)

0

P/E Ratio

0.0

ACCESS Newswire Inc is a Public Relations (PR) and Investor Relations (IR) solutions provider. The group focuses on innovation, customer service, and value-driven offerings, ACCESS Newswire empowers brands.

Access the stockcalc valuation


AEON Biopharma

AEON:ASE

Close Price

-

Our Valuation

-

% Difference

0.00

Market Cap ($M)

0

P/E Ratio

0.0

AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.

Access the stockcalc valuation


AIM ImmunoTech

AIM:ASE

Close Price

-

Our Valuation

-

% Difference

0.00

Market Cap ($M)

0

P/E Ratio

0.0

AIM ImmunoTech Inc is an immuno-pharma company focused on research and development of therapeutics to treat immune disorders and viral and cancer diseases. AIM's flagship products include Ampligen (Rintatolimod), a drug of large macromolecular RNA molecules for cancer and viral diseases, and the drug Alferon N Injection for a category of STD infection.

Access the stockcalc valuation


Air Industries

AIRI:ASE

Close Price

-

Our Valuation

-

% Difference

0.00

Market Cap ($M)

0

P/E Ratio

0.0

Air Industries Group is an aerospace and defense company. Its manufactures and designs structural parts and assemblies that focus on flight safety, including landing gear, arresting gear, engine mounts, flight controls, throttle quadrants, jet engines, and other components. The company also provides sheet metal fabrication of aerostructures, tube bending, and welding services.

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

Ambipar Emergency

AMBI:ASE

Close Price

-

Our Valuation

-

% Difference

0.00

Market Cap ($M)

0

P/E Ratio

21.9

Ambipar Emergency Response is a environmental, emergency response and industrial field service provider in Brazil with presence in 16 countries in Latin America, North America, Europe, Africa and Antarctica. The company provides customers with a full suite of environmental services organized around prevention, training and emergency response on all transportation modes.

Access the stockcalc valuation


Ambow Education Holding

AMBO:ASE

Close Price

-

Our Valuation

-

% Difference

0.00

Market Cap ($M)

0

P/E Ratio

0.0

Ambow Education Holding Ltd is a provider of educational and career enhancement services in China. It operates through CP&CE Programs. The CP&CE Programs include tutoring services and career enhancement services. Geographically all the operations function in the United States and Foreign countries.

Access the stockcalc valuation


American Shared Hospital

AMS:ASE

Close Price

-

Our Valuation

-

% Difference

0.00

Market Cap ($M)

0

P/E Ratio

5.1

American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.

Access the stockcalc valuation


Alpha Pro Tech

APT:ASE

Close Price

-

Our Valuation

-

% Difference

0.00

Market Cap ($M)

0

P/E Ratio

14.3

Alpha Pro Tech Ltd is involved in the business of developing, manufacturing, and marketing of disposable protective apparel, building supply, and infection control products principally in the United States. It operates its business through segment which includes Building Supply and Disposable Protective Apparel.

Access the stockcalc valuation


Arena Group Holdings

AREN:ASE

Close Price

-

Our Valuation

-

% Difference

0.00

Market Cap ($M)

0

P/E Ratio

0.0

The Arena Group Holdings Inc is a tech-powered media company that fuses technology, iconic brands, and marketing to deliver vibrant content and experiences that reach million users each month. The company creates robust digital destinations that delight consumers with powerful journalism, news about the things such as favorite sports teams, advice on investing, the inside scoop on personal finance, and the latest on lifestyle essentials.

Access the stockcalc valuation


Aris Mining

ARMN:ASE

Close Price

-

Our Valuation

-

% Difference

0.00

Market Cap ($M)

0

P/E Ratio

0.0

Aris Mining Corp is engaged in the acquisition, exploration, development and operation of gold properties in Colombia, Guyana and Canada. It owns and operates its Segovia Operations, Soto Norte Project and Marmato Mine in Colombia, Toroparu Project in Guyana and the Juby Project in Ontario, Canada. The company generates revenue from the sale of gold and silver.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
ACCESS Newswire and AEON Biopharma are the most undervalued Small-Cap growth stocks on the ASE. See the full list of undervalued growth stocks here: https://www.stockcalc.com/Blog/undervalued-small-cap-growth-stocks-ase-january-2025
ACCESS Newswire $ACCS and AEON Biopharma $AEON are the most undervalued Small-Cap growth stocks on the #ASE. See the full list: https://www.stockcalc.com/Blog/undervalued-small-cap-growth-stocks-ase-january-2025
ACCESS Newswire and AEON Biopharma are the most undervalued Small-Cap growth stocks on the ASE. See the full list of undervalued growth stocks here: https://www.stockcalc.com/Blog/undervalued-small-cap-growth-stocks-ase-january-2025

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.